Skip to main navigation Skip to search Skip to main content

Caspase-10: a molecular switch from cell-autonomous apoptosis to communal cell death in response to chemotherapeutic drug treatment

  • Andrea Mohr
  • , Laura Deedigan
  • , Sylwia Jencz
  • , Yasamin Mehrabadi
  • , Lily Houlden
  • , Stella Maris Albarenque
  • , Ralf Michael Zwacka

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

Abstract

The mechanisms of how chemotherapeutic drugs lead to cell cycle checkpoint regulation and DNA damage repair are well understood, but how such signals are transmitted to the cellular apoptosis machinery is less clear. We identified a novel apoptosis-inducing complex, we termed FADDosome, which is driven by ATR-dependent caspase-10 upregulation. During FADDosome-induced apoptosis, cFLIP(L) is ubiquitinated by TRAF2, leading to its degradation and subsequent FADD-dependent caspase-8 activation. Cancer cells lacking caspase-10, TRAF2 or ATR switch from this cell-autonomous suicide to a more effective, autocrine/paracrine mode of apoptosis initiated by a different complex, the FLIPosome. It leads to processing of cFLIP(L) to cFLIP(p43), TNF-alpha production and consequently, contrary to the FADDosome, p53-independent apoptosis. Thus, targeting the molecular levers that switch between these mechanisms can increase efficacy of treatment and overcome resistance in cancer cells.
Original languageEnglish (Ireland)
JournalCell Death and Differentiation
DOIs
Publication statusPublished - 3 Nov 2017

Fingerprint

Dive into the research topics of 'Caspase-10: a molecular switch from cell-autonomous apoptosis to communal cell death in response to chemotherapeutic drug treatment'. Together they form a unique fingerprint.

Cite this